Zinc Finger Nuclease (ZFN) technology is a powerful genome-editing approach that enables precise modification of DNA within living cells. It combines two key components: zinc finger proteins that recognize specific DNA sequences and a nuclease enzyme that cuts DNA at targeted locations. Together, these elements allow scientists to alter genes with remarkable specificity.

Zinc finger proteins are naturally occurring DNA-binding motifs found in many transcription factors. By engineering these proteins, researchers can design zinc fingers that bind to chosen DNA sequences. When fused with a nuclease domain, usually derived from the FokI enzyme, the resulting ZFN can introduce a double-strand break at a precise genomic location.

Once the DNA is cut, the cell’s natural repair mechanisms take over. These repair processes can be harnessed to disrupt faulty genes, correct mutations, or insert new genetic material. This ability has made ZFN technology an important tool in molecular biology, functional genomics, and therapeutic research.

ZFN technology was among the earliest gene-editing platforms developed and laid the groundwork for modern genome engineering. Its development demonstrated that targeted DNA modification was possible in human cells, opening new avenues for treating genetic disorders.

Despite the emergence of newer editing tools, ZFNs remain relevant due to their high specificity and established clinical track record. Their use continues in both research and therapeutic development, especially in areas requiring permanent genetic modification.